Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of vitamin d3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells.
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
Response: relationship between vitamin D and depression in multiple sclerosis.
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.
[Marihuana and cannobinoids as medicaments].
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
[Neuromyelitis optica spectrum disorder: a case report].
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis.
Regulatory effects of fisetin on microglial activation.
Cognitive Impairment in Multiple Sclerosis.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
Alemtuzumab Therapy for Multiple Sclerosis.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis.
Brain imaging and bladder function.

Pages